HK1091894A1 - Prion protein binding materials and methods of use - Google Patents
Prion protein binding materials and methods of useInfo
- Publication number
- HK1091894A1 HK1091894A1 HK06108070A HK06108070A HK1091894A1 HK 1091894 A1 HK1091894 A1 HK 1091894A1 HK 06108070 A HK06108070 A HK 06108070A HK 06108070 A HK06108070 A HK 06108070A HK 1091894 A1 HK1091894 A1 HK 1091894A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- methods
- protein binding
- prion protein
- binding materials
- materials
- Prior art date
Links
- 102000029797 Prion Human genes 0.000 title 1
- 108091000054 Prion Proteins 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46047403P | 2003-04-04 | 2003-04-04 | |
| PCT/US2004/010315 WO2004090102A2 (en) | 2003-04-04 | 2004-04-02 | Prion protein binding materials and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1091894A1 true HK1091894A1 (en) | 2007-01-26 |
Family
ID=33159772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK06108070A HK1091894A1 (en) | 2003-04-04 | 2006-07-18 | Prion protein binding materials and methods of use |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7393658B2 (xx) |
| EP (1) | EP1615992B1 (xx) |
| JP (1) | JP4783727B2 (xx) |
| CN (1) | CN1842707B (xx) |
| AU (1) | AU2004227389B2 (xx) |
| CA (1) | CA2521438C (xx) |
| DK (1) | DK1615992T3 (xx) |
| EG (1) | EG26681A (xx) |
| ES (1) | ES2436638T3 (xx) |
| HK (1) | HK1091894A1 (xx) |
| IL (1) | IL171279A (xx) |
| NZ (1) | NZ543371A (xx) |
| PL (1) | PL1615992T3 (xx) |
| PT (1) | PT1615992E (xx) |
| SG (1) | SG187269A1 (xx) |
| WO (1) | WO2004090102A2 (xx) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2836951C (en) * | 2002-12-03 | 2017-01-10 | North Carolina State University | Prion protein ligands and methods of use |
| JP4428616B2 (ja) * | 2003-05-06 | 2010-03-10 | オルガノ株式会社 | グラフト修飾有機多孔質体及びその製造方法並びに吸着剤、クロマトグラフィー用充填剤及びイオン交換体 |
| US20060035242A1 (en) * | 2004-08-13 | 2006-02-16 | Michelitsch Melissa D | Prion-specific peptide reagents |
| JP4709149B2 (ja) | 2003-08-13 | 2011-06-22 | ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド | プリオン特異的ペプチド試薬 |
| US20050054003A1 (en) * | 2003-09-10 | 2005-03-10 | Stenland Christopher J. | Prion clearance using particulate metal oxides |
| JP4864891B2 (ja) * | 2004-06-09 | 2012-02-01 | パサジャン リムーヴァル アンド ダイアグナスティック テクノロジーズ インコーポレイテッド | サンプルから標的因子を除去するためのデバイス及び方法 |
| WO2006076683A2 (en) * | 2005-01-13 | 2006-07-20 | Novartis Vaccines And Diagnostics Inc. | Isolation and detection of pathogenic prions |
| AU2006204705C1 (en) * | 2005-01-13 | 2012-07-05 | Novartis Vaccines And Diagnostics, Inc. | ELISA assays using prion-specific peptide reagents |
| WO2006076497A2 (en) * | 2005-01-13 | 2006-07-20 | Novartis Vaccines And Diagnostics Inc. | Osplation of pathogenic prions |
| EP1931695B1 (en) * | 2005-09-09 | 2013-04-10 | Novartis AG | Prion-specific peptoid reagents |
| FR2891747B1 (fr) | 2005-10-10 | 2007-12-14 | Maco Pharma Sa | Unite de filtration pour l'elimination selective d'une substance cible |
| WO2008001802A1 (fr) * | 2006-06-27 | 2008-01-03 | Asahi Kasei Kabushiki Kaisha | Substrat pour traitement de fluide biologique |
| EP2050457B1 (en) * | 2006-07-12 | 2012-06-27 | Asahi Kasei Medical Co., Ltd. | Method of removing abnormal prion from blood preparation |
| BRPI0910550A2 (pt) * | 2008-04-30 | 2015-09-29 | Novartis Ag | ensaio para confôrmeros patogênicos |
| RU2559570C2 (ru) | 2009-04-15 | 2015-08-10 | АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи | Композиции без приона на основе наночастиц и способы их получения |
| PL221899B1 (pl) * | 2011-05-06 | 2016-06-30 | Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną | Czysta albumina oraz sposób jej otrzymywania i detekcji |
| FR2983735B1 (fr) * | 2011-12-13 | 2019-12-13 | Maco Pharma | Nouvelle utilisation d'un materiau capable de lier la proteine prion |
| RU2018107453A (ru) | 2015-08-10 | 2019-09-12 | Эссенликс Корп. | Устройства для анализов и способы в биологии/химии, предусматривающие упрощенные стадии, образцы небольшого объема, повышенную скорость и простоту применения |
| CN112462055B (zh) | 2015-09-14 | 2024-06-07 | 上海宜晟生物科技有限公司 | 用于分析样品，尤其是血液，的装置和***以及其使用方法 |
| US10132794B2 (en) | 2015-09-14 | 2018-11-20 | Essenlix Corporation | Device and system for collecting and analyzing vapor condensate, particularly exhaled breath condensate, as well as method of using the same |
| EP3558121B1 (en) | 2016-12-21 | 2022-06-08 | Essenlix Corporation | Devices and methods for authenticating a sample and use of the same |
| CA3052786A1 (en) | 2017-02-07 | 2018-08-16 | Essenlix Corporation | Compressed open flow assay and use |
| CA3053005A1 (en) | 2017-02-08 | 2018-08-16 | Essenlix Corporation | Sample collection and handling for delayed analysis |
| CN111936837B (zh) | 2017-02-08 | 2024-06-07 | 上海宜晟生物科技有限公司 | Qmax测定及应用 |
| CA3053002A1 (en) | 2017-02-08 | 2018-08-16 | Essenlix Corp. | Bio/chemical material extraction and assay |
| US11883824B2 (en) | 2017-02-09 | 2024-01-30 | Essenlix Corporation | Assay using different spacing heights |
| WO2018148609A2 (en) | 2017-02-09 | 2018-08-16 | Essenlix Corporation | Colorimetric assays |
| CA3053132A1 (en) | 2017-02-09 | 2018-08-16 | Essenlix Corp. | Assay with amplification |
| US10966634B2 (en) | 2017-02-16 | 2021-04-06 | Essenlix Corporation | Assay with textured surface |
| US11243201B2 (en) | 2017-08-01 | 2022-02-08 | Essenlix Corporation | Sample collection, holding and assaying |
| US11280706B2 (en) | 2017-08-01 | 2022-03-22 | Essenlix Corporation | Dilution calibration |
| US11725227B2 (en) | 2017-08-01 | 2023-08-15 | Essenlix Corporation | Devices and methods for examining drug effects on microorganisms |
| US11393561B2 (en) | 2017-10-13 | 2022-07-19 | Essenlix Corporation | Devices and methods for authenticating a medical test and use of the same |
| US11237113B2 (en) | 2017-10-26 | 2022-02-01 | Essenlix Corporation | Rapid pH measurement |
| US11609224B2 (en) | 2017-10-26 | 2023-03-21 | Essenlix Corporation | Devices and methods for white blood cell analyses |
| US10807095B2 (en) | 2017-10-26 | 2020-10-20 | Essenlix Corporation | Making and tracking assay card |
| WO2019118652A1 (en) | 2017-12-12 | 2019-06-20 | Essenlix Corporation | Sample manipulation and assay with rapid temperature change |
| WO2019118936A2 (en) | 2017-12-14 | 2019-06-20 | Essenlix Corporation | Devices, systems, and methods for monitoring hair |
| WO2019140334A1 (en) | 2018-01-11 | 2019-07-18 | Essenlix Corporation | Homogeneous assay (ii) |
| US11885952B2 (en) | 2018-07-30 | 2024-01-30 | Essenlix Corporation | Optics, device, and system for assaying and imaging |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5133866A (en) | 1988-03-24 | 1992-07-28 | Terrapin Technologies, Inc. | Method to identify analyte-bending ligands |
| US5010175A (en) | 1988-05-02 | 1991-04-23 | The Regents Of The University Of California | General method for producing and selecting peptides with specific properties |
| AU6753390A (en) | 1989-10-02 | 1991-04-28 | University Of Michigan, The | Bioanalytical detection system |
| US5498538A (en) | 1990-02-15 | 1996-03-12 | The University Of North Carolina At Chapel Hill | Totally synthetic affinity reagents |
| US5650489A (en) | 1990-07-02 | 1997-07-22 | The Arizona Board Of Regents | Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| CA2124953C (en) | 1991-12-03 | 2008-02-05 | Robert V. Fishleigh | Peptides related to prion proteins |
| US5312730A (en) | 1992-05-27 | 1994-05-17 | Ciba Corning Diagnostics Corp. | Immune complex transfer with lypophilic bridge |
| JPH08178926A (ja) | 1994-10-25 | 1996-07-12 | Sumitomo Pharmaceut Co Ltd | イムノアッセイプレートおよびその用途 |
| US5834318A (en) | 1995-05-10 | 1998-11-10 | Bayer Corporation | Screening of combinatorial peptide libraries for selection of peptide ligand useful in affinity purification of target proteins |
| US5750361A (en) | 1995-11-02 | 1998-05-12 | The Regents Of The University Of California | Formation and use of prion protein (PRP) complexes |
| DE69724619T2 (de) * | 1996-05-14 | 2004-07-01 | Winnacker, Ernst-Ludwig, Prof. | Chaperone, die prionproteine binden und zwischen den isoformen prpc und prpsc unterscheiden können |
| US5808011A (en) | 1996-07-01 | 1998-09-15 | Biopure Corporation | Method for chromatographic removal of prions |
| US6221614B1 (en) * | 1997-02-21 | 2001-04-24 | The Regents Of The University Of California | Removal of prions from blood, plasma and other liquids |
| US6750025B1 (en) * | 1998-07-09 | 2004-06-15 | V.I. Technologies, Inc. | Method of detecting and isolating prion protein and variants thereof |
| US6437102B1 (en) * | 1999-11-24 | 2002-08-20 | Bayer Corporation | Method of separating prions from biological materials |
| WO2001077687A2 (en) * | 2000-04-05 | 2001-10-18 | V.I Technologies, Inc. | Prion-binding peptidic ligands and methods of using same |
| IES20010042A2 (en) * | 2001-01-19 | 2002-12-11 | Enfer Technology Ltd | Test for transmissible spongiform encephalopathies |
| DE10107083C2 (de) * | 2001-02-13 | 2003-02-20 | Abdulgabar Salama | Pentosan Polysulfat als Ligand zum Nachweis von Prionen |
| WO2003016904A2 (en) | 2001-08-13 | 2003-02-27 | Campbell Douglas A | Peptide sequence tags and method of using same |
| DE10152677A1 (de) | 2001-10-19 | 2003-05-08 | Aventis Behring Gmbh | Antikörper zum spezifischen Nachweis von pathogenen Prionen humanen Ursprungs und damit durchgeführten Nachweisverfahren |
-
2004
- 2004-04-02 SG SG2010062925A patent/SG187269A1/en unknown
- 2004-04-02 CN CN2004800156762A patent/CN1842707B/zh not_active Expired - Lifetime
- 2004-04-02 ES ES04758843T patent/ES2436638T3/es not_active Expired - Lifetime
- 2004-04-02 PL PL04758843T patent/PL1615992T3/pl unknown
- 2004-04-02 EP EP20040758843 patent/EP1615992B1/en not_active Expired - Lifetime
- 2004-04-02 CA CA2521438A patent/CA2521438C/en not_active Expired - Lifetime
- 2004-04-02 US US10/817,117 patent/US7393658B2/en not_active Expired - Lifetime
- 2004-04-02 DK DK04758843T patent/DK1615992T3/da active
- 2004-04-02 PT PT47588439T patent/PT1615992E/pt unknown
- 2004-04-02 WO PCT/US2004/010315 patent/WO2004090102A2/en active Application Filing
- 2004-04-02 NZ NZ543371A patent/NZ543371A/en unknown
- 2004-04-02 JP JP2006509670A patent/JP4783727B2/ja not_active Expired - Lifetime
- 2004-04-02 AU AU2004227389A patent/AU2004227389B2/en not_active Expired
-
2005
- 2005-10-04 EG EGPCTNA2005000616A patent/EG26681A/en active
- 2005-10-06 IL IL171279A patent/IL171279A/en not_active IP Right Cessation
-
2006
- 2006-07-18 HK HK06108070A patent/HK1091894A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004090102A2 (en) | 2004-10-21 |
| PL1615992T3 (pl) | 2014-03-31 |
| EP1615992B1 (en) | 2013-08-28 |
| CA2521438A1 (en) | 2004-10-21 |
| SG187269A1 (en) | 2013-02-28 |
| PT1615992E (pt) | 2013-11-29 |
| US7393658B2 (en) | 2008-07-01 |
| NZ543371A (en) | 2008-04-30 |
| CN1842707B (zh) | 2012-06-27 |
| EP1615992A4 (en) | 2007-11-07 |
| AU2004227389A1 (en) | 2004-10-21 |
| CA2521438C (en) | 2014-03-25 |
| JP4783727B2 (ja) | 2011-09-28 |
| ES2436638T3 (es) | 2014-01-03 |
| AU2004227389B2 (en) | 2010-09-16 |
| WO2004090102A3 (en) | 2006-03-16 |
| EP1615992A2 (en) | 2006-01-18 |
| CN1842707A (zh) | 2006-10-04 |
| JP2006522344A (ja) | 2006-09-28 |
| DK1615992T3 (da) | 2013-12-09 |
| EG26681A (en) | 2014-06-01 |
| US20050014196A1 (en) | 2005-01-20 |
| IL171279A (en) | 2014-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1091894A1 (en) | Prion protein binding materials and methods of use | |
| ZA200702634B (en) | Prion protein binding materials and methods of use | |
| EP1660013A4 (en) | BIOMATERIAL AND PROTEIN BIOCOACERVATES, METHODS OF MAKING AND USING THEM | |
| IL173322A0 (en) | Binding constructs and methods for use thereof | |
| IL169638A0 (en) | Soluble fcyr fusion proteins and methods of use thereof | |
| EP1482984A4 (en) | REPLACEMENT ANTIBODIES AND METHOD FOR THEIR MANUFACTURE AND USE | |
| EP1501514A4 (en) | PROTEIN-KINASE MODULATORS AND METHODS OF USE | |
| EP1736541A4 (en) | NEW GALECTIN 9 MODIFICATION PROTEIN AND ITS USE | |
| EP1794589A4 (en) | PROTEIN ARRAYS AND METHOD OF USE THEREOF | |
| AU2003265522A1 (en) | FCGammaRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF | |
| EP1767634A4 (en) | NEW GALECTIN 8 MODIFICATION PROTEIN AND USE THEREOF | |
| EP1699485A4 (en) | ANTI-HYDROLYSATE ANTIBODIES AND ITS USES | |
| IL182749A0 (en) | Vwfa and/or ant_ig domain containing proteins | |
| IL172510A0 (en) | Antibodies and uses thereof | |
| GB0323238D0 (en) | Synthetic LG binding domains of protein L | |
| EP1589033A4 (en) | ANTIBODY AND ITS USE | |
| GB0324457D0 (en) | Modified peptides and their uses | |
| HK1209050A1 (en) | Survivin-derived peptides and use thereof | |
| EP1633850A4 (en) | OVR115 ANTIBODY COMPOSITIONS AND METHODS OF USE | |
| GB0416699D0 (en) | Prion protein ligands and methods of use | |
| AU2003261362A8 (en) | Lipid binding molecules and methods of use | |
| EP1541677A4 (en) | NEW PROTEINS AND USE THEREOF | |
| EP1577322A4 (en) | NEW PROTEINS AND THEIR USE | |
| AU2003296232A1 (en) | A human liver regeneration associated protein and the use of it | |
| EP1379548A4 (en) | NEW BINDING INTERACTIONS OF THE RGS9 PROTEIN AND METHOD OF USE THEREOF |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PE | Patent expired |
Effective date: 20240329 |